Skip to main content

Advertisement

Table 4 Prescription drug expenditures in china by treatment site (US$, billions, nominal)

From: Healthcare reform in the United States and China: pharmaceutical market implications

  General hospitals Specialized hospitals CHCs THCs TCM Total Rx
  Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient  
2011 38.2 22.8 4.6 2.8 0.4 3.5 2.6 3.3 0.6 1.0 79.9
2012 46.8 26.8 5.9 3.5 0.5 4.2 2.6 3.3 0.8 1.2 95.4
2015 81.8 41.2 11.4 6.1 0.8 6.6 2.4 2.9 1.4 2.1 156.8
2020 148.7 61.9 24.3 11.4 1.5 10.8 1.5 1.7 3.5 4.4 269.6
  1. Notes: Figures initially calculated in RMB (Renminbi), converted to US$ using actual rates through 2013 and projections of $1: RMB 5.8 for 2015 and 1$: 5.5 RMB for 2020. These align to market expectations for exchange rates and policy statements from the People’s Bank of China. Total prescription drug sales for 2011 and 2012 differ from Table 5 due to discrepancies in the original data sources.
  2. Source: People’s Republic of China (2012) Health Statistical Yearbook, Beijing: P.R. China.